"Oh shit, I forgot." She sighed. "There was so much going on, with Mom and all the rest, that it completely slipped my—”
"Don't worry about it," he said with a sigh.
Come on, Ally, she thought, this could be really important. You've got to get focused.
"I'll try to remember tomorrow."
"I do think it's kind of vital. But be careful not to mention my name. I've ... I've just acquired some problems of my own with the Gerex Corporation."
"What kind of 'problems'?"
"Let me take a rain check on answering that. Suffice to say, they're not thrilled about the idea that I'm doing a book in which they're prominently featured." He paused. "Look, Ally, there's a lot going on here. Including that patient who was dropped for some reason that nobody wants to disclose. But if you do decide to do it you couldn't have a better physician. Karl Van de Vliet is quite possibly the world's leading researcher in stem cell technology. On the other hand, this is the first time there've been actual human trials. If anybody tells you there's no risk, then they're not behaving ethically."
"Well, the way things stand now, I'm due out there at the institute at ten a.m. tomorrow. If I want to, I can be formally entered into the clinical trials on the spot. I've passed my qualifying exam."
"You know the trials are almost over. It's like they're taking you at the last minute."
"That's what he said. I'm going to be the last ... whatever. My friend Jennifer just called me a guinea pig. Van de Vliet also said I'd have to stay out there for at least a couple of weeks, probably longer. That's going to be a bloody drag, since things are really busy down at CitiSpace now."